Quest Diagnostics的高管在盈利强劲并加息后抛售了股票。 A Quest Diagnostics exec sold shares after strong earnings and raised guidance.

2026年3月4日, Quest Diagnotistics的一位资深副总裁以每股204.86美元的价格出售了2 628股股份, On March 4, 2026, a senior vice president at Quest Diagnostics sold 2,628 shares at $204.86 per share, reducing their stake by 16.35% to 13,441 shares, valued at about $2.75 million. 该公司在2月10日报告Q4收入丰厚,为2.42 EPS,击打估计数为0.07美元,收入增加7.1%。 The company reported strong Q4 earnings on February 10, with $2.42 EPS, beating estimates by $0.07, and a 7.1% revenue increase. Quest Diagnostics将其2026年全年指引提高至每股9.45至9.65美元，季度股息提高至0.86美元，并维持股票回购计划。 Quest Diagnostics raised its 2026 full-year guidance to $9.45–$9.65 per share, increased its quarterly dividend to $0.86, and maintains a share repurchase program. 库存于3月6日以199.37美元关闭, " 机动购买 " 评级一致,目标价格为210.29美元。 The stock closed at $199.37 on March 6, with a consensus “Moderate Buy” rating and a target price of $210.29.